Citius Oncology, Inc. (CTOR)
0.6639
-0.02
(-3.38%)
USD |
NASDAQ |
Apr 07, 16:00
0.6493
-0.01
(-2.20%)
After-Hours: 20:00
Citius Oncology EPS Diluted (Quarterly) : -0.0633 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -0.3824 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.534M |
| Revenue (Quarterly) | 3.944M |
| Total Expenses (Quarterly) | 9.478M |
| Enterprise Value | 55.11M |
| Gross Profit Margin (Quarterly) | 79.99% |
| Profit Margin (Quarterly) | -140.3% |
| Earnings Yield | -49.11% |
| Normalized Earnings Yield | -49.13 |